Virtus Investment Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,315
Closed -$346K 505
2017
Q4
$346K Sell
3,315
-43
-1% -$4.85K 0.04% 336
2017
Q3
$490K Sell
3,358
-468
-12% -$63.7K 0.05% 317
2017
Q2
$497K Sell
3,826
-660
-15% -$80.9K 0.05% 322
2017
Q1
$558K Buy
+4,486
New +$537K 0.05% 314
2016
Q4
Sell
-16,534
Closed -$1.73M 551
2016
Q3
$1.73M Buy
+16,534
New +$1.79M 0.11% 234

Other funds holding CELG

Virtus Investment Advisers's CELG Position: Q1 2018 in Review

Virtus Investment Advisers sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 3,315 shares — an estimated $346K sold.

Virtus Investment Advisers first reported a position in CELG in Q3 2016 and held it in 5 quarters. The position peaked at $1.73M in Q3 2016. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Virtus Investment Advisers reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Virtus Investment Advisers sold 3,315 Celgene Corp shares in Q1 2018, an estimated $346K.
  • Virtus Investment Advisers first reported a position in Celgene Corp in Q3 2016 and held it in 5 quarters.
  • Virtus Investment Advisers's Celgene Corp position peaked at $1.73M in Q3 2016.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Virtus Investment Advisers's 13F filing for Q1 2018, filed 15 May 2018.